H Niitani, A Suzuki, T Taniguchi, N Saijo, I Kawase, K Kimura. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Dextrans/administration & dosageDextrans/pharmacologyDrug SynergismDrug Therapy, CombinationFibrinolysin/biosynthesisFibrinolytic Agents/administration & dosageHumansLipoprotein Lipase/bloodLung Neoplasms/drug therapyLung Neoplasms/mortalityLung Neoplasms/pathologyLysosomes/drug effectsMitomycins/administration & dosageMitomycins/adverse effectsNeoplasm MetastasisPlasminogen/metabolismTime FactorsUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/pharmacology
Substances： See more » DextransFibrinolytic AgentsMitomycinsPlasminogenLipoprotein LipaseFibrinolysinUrokinase-Type Plasminogen Activator
Year: 1974 PMID： 4279834
Source DB: PubMed Journal: Gan ISSN： 0016-450X